By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Myriad Genetics said after the close of the market on Tuesday that sales of BRACAnalysis products drove its total revenues up 13 percent year over year in its fiscal third quarter.

Revenues for Myriad during the three months ended March 31 totaled $102.4 million, compared to $90.8 million a year ago, exceeding consensus Wall Street forecasts for $98.2 million in revenue.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.